MAM
ACER

Meeder Asset Management’s Acer Therapeutics Inc ACER Stock Holding History

Meeder Asset Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-669
Closed -$1K – 2583
2020
Q1 		$1K Sell
669
-876
-57% -$3.21K ﹤0.01% 2258
2019
Q4 		$6K Sell
1,545
-5,548
-78% -$18.9K ﹤0.01% 1750
2019
Q3 		$21K Buy
+7,093
New +$20.8K ﹤0.01% 1300

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Meeder Asset Management's ACER Position: Q2 2020 in Review

Meeder Asset Management sold out of Acer Therapeutics Inc (ACER) in Q2 2020, closing a stake of 669 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in ACER in Q3 2019 and held it in 3 quarters. The position peaked at $21K in Q3 2019. 34 funds tracked by Wall St. Rank hold ACER as of Q2 2020.

  • Meeder Asset Management reported no remaining Acer Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 669 Acer Therapeutics Inc shares in Q2 2020, an estimated $1K.
  • Meeder Asset Management first reported a position in Acer Therapeutics Inc in Q3 2019 and held it in 3 quarters.
  • Meeder Asset Management's Acer Therapeutics Inc position peaked at $21K in Q3 2019.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.